Brief: Tracon Pharmaceuticals Posts Qtrly Loss Per Share $0.40
15/03/2022 20:04
March 15 (Reuters) - TRACON Pharmaceuticals Inc TCON.O :
* TRACON PHARMACEUTICALS REPORTS FOURTH QUARTER AND YEAR-END
2021
FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
* TRACON PHARMACEUTICALS INC - CASH, CASH EQUIVALENTS AND
SHORT-TERM INVESTMENTS WERE $24.1 MILLION AT DECEMBER 31, 2021
* TRACON PHARMACEUTICALS INC QTRLY LOSS PER SHARE $0.40
* TRACON PHARMACEUTICALS INC - INITIATING COMBINATION TRIAL
OF
PROPRIETARY CTLA-4 WITH ENVAFOLIMAB IN 2022
Source text for Eikon: ID:nGNX269b1h
Further company coverage: TCON.O
((reuters.briefs@thomsonreuters.com;))
Recent news on TRACON Pharmaceuticals
See all newsBrief: TRACON Pharmaceuticals Says ENVASARC Trial ORR Is 5%, Does Not Meet 11% Endpoint
Tracon Pharmaceuticals Inc Reports Results For The Quarter Ended In March: Earnings Summary
Tracon Pharmaceuticals Inc Expected To Post A Loss Of $1.19 A Share: Earnings Preview
Tracon Pharmaceuticals Inc Expected To Post A Loss Of $1.19 A Share: Earnings Preview
Brief: Tracon Pharmaceuticals Files For Offering Of Common Stock, Pre-Funded Warrants